90 related articles for article (PubMed ID: 17175215)
21. A novel transgenic mouse model produced from lentiviral germline integration for the study of beta-thalassemia gene therapy.
Li W; Xie S; Guo X; Gong X; Wang S; Lin D; Zhang J; Ren Z; Huang S; Zeng F; Zeng Y
Haematologica; 2008 Mar; 93(3):356-62. PubMed ID: 18268280
[TBL] [Abstract][Full Text] [Related]
22. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC
J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149
[TBL] [Abstract][Full Text] [Related]
23. Identification of early tolerance regulator genes induced by allochimeric therapy using microarray-based genomewide scan.
Liu D; Shen XD; Fang Z; Gao F; Semiletova N; Cao MJ; Busuttil RW; Kupiec-Weglinski JW; Ghobrial RM
Transplant Proc; 2005 May; 37(4):1942-3. PubMed ID: 15919512
[TBL] [Abstract][Full Text] [Related]
24. Potential of aspirin to inhibit thrombotic microangiopathy in alpha1,3-galactosyltransferase gene-knockout pig hearts after transplantation in baboons.
Dor FJ; Kuwaki K; Tseng YL; Shimizu A; Houser SL; Yamada K; Hawley RJ; Patience C; Awwad M; Fishman JA; Robson SC; Sachs DH; Schuurman HJ; Cooper DK
Transplant Proc; 2005; 37(1):489-90. PubMed ID: 15808685
[TBL] [Abstract][Full Text] [Related]
25. Immunity to islet grafts transduced with adenovirus vectors does not inhibit long-term islet function.
Cheng J; Sun J; Sung RS
Transpl Immunol; 2009 May; 21(1):33-42. PubMed ID: 19224710
[TBL] [Abstract][Full Text] [Related]
26. Induction of molecular chimerism by gene therapy prevents antibody-mediated heart transplant rejection.
Bracy JL; Chase CM; Russell PS; Mauiyyedi S; Colvin RB; Iacomini J
Gene Ther; 2001 Nov; 8(22):1738-44. PubMed ID: 11892842
[TBL] [Abstract][Full Text] [Related]
27. Differences in lymphocyte gene expression between tolerant and syngeneic liver grafted rats.
Fujino M; Kitazawa Y; Kawasaki M; Funeshima N; Kimura H; Nakajima T; Saito H; Li XK
Liver Transpl; 2004 Mar; 10(3):379-91. PubMed ID: 15004765
[TBL] [Abstract][Full Text] [Related]
28. Lentivirus gene therapy for purine nucleoside phosphorylase deficiency.
Liao P; Toro A; Min W; Lee S; Roifman CM; Grunebaum E
J Gene Med; 2008 Dec; 10(12):1282-93. PubMed ID: 18924118
[TBL] [Abstract][Full Text] [Related]
29. Simultaneous protection against allograft rejection and graft-versus-host disease after total lymphoid irradiation: role of natural killer T cells.
Liu YP; Li Z; Nador RG; Strober S
Transplantation; 2008 Feb; 85(4):607-14. PubMed ID: 18347541
[TBL] [Abstract][Full Text] [Related]
30. Expression of the chemokine antagonist vMIP II using a non-viral vector can prolong corneal allograft survival.
Pillai RG; Beutelspacher SC; Larkin DF; George AJ
Transplantation; 2008 Jun; 85(11):1640-7. PubMed ID: 18551072
[TBL] [Abstract][Full Text] [Related]
31. Intragraft TNF receptor signaling contributes to activation of innate and adaptive immunity in a renal allograft model.
Hummel M; Kurian SM; Lin S; Borodyanskiy A; Zhang Z; Li Z; Kim SJ; Salomon DR; Abecassis M
Transplantation; 2009 Jan; 87(2):178-88. PubMed ID: 19155971
[TBL] [Abstract][Full Text] [Related]
32. Expression of human factor IX gene in murine plasma through lentiviral vector-infected haematopoietic stem cells.
Chen H; Yao H; Huang L; Shen Q; Jia W; Xue J
Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1196-201. PubMed ID: 17184501
[TBL] [Abstract][Full Text] [Related]
33. Engraftment of genetically modified bone marrow cells in sensitized hosts.
Bracy J; Iacomini J
Mol Ther; 2002 Aug; 6(2):252-7. PubMed ID: 12161192
[TBL] [Abstract][Full Text] [Related]
34. Tolerance induction by lentiviral gene therapy with a nonmyeloablative regimen.
Mitsuhashi N; Fischer-Lougheed J; Shulkin I; Kleihauer A; Kohn DB; Weinberg KI; Starnes VA; Kearns-Jonker M
Blood; 2006 Mar; 107(6):2286-93. PubMed ID: 16291598
[TBL] [Abstract][Full Text] [Related]
35. Comparison of toxicogenomic profiles of two murine strains treated with HIV-1-based vectors for gene therapy.
Zhao Y; Keating K; Thorpe R
Toxicol Appl Pharmacol; 2007 Dec; 225(2):189-97. PubMed ID: 17904176
[TBL] [Abstract][Full Text] [Related]
36. Elicited antibodies in baboons exposed to tissues from alpha1,3-galactosyltransferase gene-knockout pigs.
Tseng YL; Moran K; Dor FJ; Sanderson TM; Li W; Lancos CJ; Schuurman HJ; Sachs DH; Cooper DK
Transplantation; 2006 Apr; 81(7):1058-62. PubMed ID: 16612284
[TBL] [Abstract][Full Text] [Related]
37. Partial phenotypic correction and immune tolerance induction to enzyme replacement therapy after hematopoietic stem cell gene transfer of alpha-glucosidase in Pompe disease.
Douillard-Guilloux G; Richard E; Batista L; Caillaud C
J Gene Med; 2009 Apr; 11(4):279-87. PubMed ID: 19263466
[TBL] [Abstract][Full Text] [Related]
38. Immune responses to alpha1,3 galactosyltransferase knockout pigs.
Puga Yung G; Schneider MK; Seebach JD
Curr Opin Organ Transplant; 2009 Apr; 14(2):154-60. PubMed ID: 19300259
[TBL] [Abstract][Full Text] [Related]
39. Glycolipid studies in small intestine and pancreas of alpha1,3-galactosyltransferase knockout miniature swine: alpha1,3GALT-KO animals lack alphaGAL antigens and contain novel blood group H compounds.
Diswall M; Angström J; Schuurman HJ; Dor FJ; Rydberg L; Breimer ME
Transplant Proc; 2008 Mar; 40(2):543-6. PubMed ID: 18374124
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-22 deficiency accelerates the rejection of full major histocompatibility complex-disparate heart allografts.
Kapessidou P; Poulin L; Dumoutier L; Goldman M; Renauld JC; Braun MY
Transplant Proc; 2008 Jun; 40(5):1593-7. PubMed ID: 18589157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
